OFF-BRAND IMATINIB: A COST-EFFECTIVE ALTERNATIVE?

The emergence of generic imatinib represents a substantial possibility for patients battling a certain type of cancer and other illnesses. Original brand-name imatinib, commonly known as Gleevec, carries a considerable price cost, frequently making it accessibility for some individuals. Generic v